Does thrombophilia testing help in the clinical management of patients?

British Journal of Haematology

Volumn 143, Issue 3, 2008, Pages 321-335

  Middeldorp, Saskia ^a   Van Hylckama Vlieg, Astrid ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiovascular diseases; Pregnancy complications; Pulmonary embolism; Thrombophilia; Venous thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ACTIVATED PROTEIN C; ANTICOAGULANT AGENT; ANTITHROMBIN; ANTIVITAMIN K; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; D DIMER; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; ORAL CONTRACEPTIVE AGENT; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN;

ACTIVATED PROTEIN C RESISTANCE; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ANTITHROMBIN DEFICIENCY; ARTERY THROMBOSIS; BLEEDING; BLOOD CLOTTING FACTOR 5 DEFICIENCY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CIGARETTE SMOKING; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DEEP VEIN THROMBOSIS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; GENE MUTATION; GENETIC DISORDER; GENETIC RISK; GENETIC SCREENING; HEART INFARCTION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INCIDENCE; LABORATORY TEST; OSTEOPOROSIS; PREGNANCY COMPLICATION; PREVALENCE; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; REVIEW; SECONDARY PREVENTION; SPONTANEOUS ABORTION; STROKE; THROMBOCYTOPENIA; THROMBOPHILIA; TRANSIENT ISCHEMIC ATTACK; VEIN THROMBOSIS;

FEMALE; HUMANS; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RECURRENCE; THROMBOPHILIA; THROMBOSIS; VENOUS THROMBOSIS;

EID: 54049096018     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07339.x     Document Type: Review

References (181)

1. Aparicio, C. Dahlbäck, B. (1996) Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gln mutation in the factor V gene. The Biochemical Journal, 313 (Pt 2 467 472.
2. Arima, T., Motomura, M., Nishiura, Y., Tsujihata, M., Okajima, K., Abe, H. Nagataki, S. (1992) Cerebral infarction in a heterozygote with variant antithrombin III. Stroke, 23, 1822 1825.
3. Atherosclerosis Thrombosis and Vascular Biology Italian Study Group (2003) No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation, 107, 1117 1122.
4. Austin, H., Chimowitz, M.I., Hill, H.A., Chaturvedi, S., Wechsler, L.R., Wityk, R.J., Walz, E., Wilterdink, J.L., Coull, B., Sila, C.A., Mitsias, P., Evatt, B. Hooper, W.C. (2002) Cryptogenic stroke in relation to genetic variation in clotting factors and other genetic polymorphisms among young men and women. Stroke, 33, 2762 2768.
5. Baglin, T., Luddington, R., Brown, K. Baglin, C. (2003) Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet, 362, 523 526.
6. Bank, I., Libourel, E.J., Middeldorp, S., van der Meer, J. Buller, H.R. (2003) High rate of skin complications due to low-molecular-weight heparins in pregnant women. Journal of Thrombosis and Haemostasis, 1, 859 861.
7. Bank, I., Libourel, E.J., Middeldorp, S., van Pampus, E.C.M., Koopman, M.M.W., Hamulyak, K., Prins, M.H., van der Meer, J. Buller, H.R. (2004a) Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study. Archives of Internal Medicine, 164, 1932 1937.
8. Bank, I., Scavenius, M.P.R.B., Buller, H.R. Middeldorp, S. (2004b) Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice. Thrombosis Research, 113, 7 12.
9. Bank, I., Libourel, E.J., Middeldorp, S., Hamulyak, K., van Pampus, E.C.M., Koopman, M.M.W., Prins, M.H., van der Meer, J. Buller, H.R. (2005) Elevated levels of FVIII:c within families are associated with an increased risk for venous and arterial thrombosis. Journal of Thrombosis and Haemostasis, 3, 79 84.
10. Beattie, S., Norton, M. Doll, D. (1997) Coronary thrombosis associated with inherited protein S deficiency: a case report. Heart and Lung, 26, 76 79.
11. Bertina, R.M., Broekmans, A.W., van der Linden, I. Mertens, K. (1982) Protein C deficiency in a Dutch family with thrombotic disease. Thrombosis & Haemostasis, 48, 1 5.
12. Bertina, R.M., Koeleman, B.P., Koster, T., Rosendaal, F.R., Dirven, R.J., de Ronde, H., van der Velden, P.A. Reitsma, P.H. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 369, 64 67.
13. Bizzaro, N., Ghirardello, A., Zampieri, S., Iaccarino, L., Tozzoli, R., Ruffatti, A., Villalta, D., Tonutti, E. Doria, A. (2007) Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15-year longitudinal study. Journal of Thrombosis and Haemostasis, 5, 1158 1164.
14. Bobrow, R.S. (2005) Excess factor VIII: a common cause of hypercoagulability. The Journal of the American Board of Family Practice, 18, 147 149.
15. Boekholdt, S.M., Bijsterveld, N.R., Moons, A.H., Levi, M., Buller, H.R. Peters, R.J. (2001) Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review. Circulation, 104, 3063 3068.
16. van Boven, H.H., Reitsma, P.H., Rosendaal, F.R., Bayston, T.A., Chowdhury, V., Bauer, K.A., Scharrer, I., Conard, J. Lane, D.A. (1996) Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency. Thrombosis & Haemostasis, 75, 417 421.
17. Branson, H.E., Katz, J., Marble, R. Griffin, J.H. (1983) Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant. Lancet, 2, 1165 1168.
18. Brenner, B., Hoffman, R., Carp, H., Dulitzky, M., Younis, J. for the LIVE-ENOX Investigators (2005) Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. Journal of Thrombosis and Haemostasis, 3, 227 229.
19. Brown, K., Luddington, R., Williamson, D., Baker, P. Baglin, T. (1997) Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′-untranslated region of the prothrombin gene. British Journal of Haematology, 98, 907 909.
20. Buller, H.R., Agnelli, G., Hull, R.D., Hyers, T.M., Prins, M.H. Raskob, G.E. (2004) Antithrombotic therapy for venous thromboembolic disease. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 126, 401S 428S.
21. Carod-Artal, F.J., Nunes, S.V., Portugal, D., Silva, T.V. Vargas, A.P. (2005) Ischemic stroke subtypes and thrombophilia in young and elderly Brazilian stroke patients admitted to a rehabilitation hospital. Stroke, 36, 2012 2014.
22. Christiansen, S.C., Cannegieter, S.C., Koster, T., Vandenbroucke, J.P. Rosendaal, F.R. (2005) Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA, 293, 2352 2361.
23. Cohn, D.M., Vansenne, F., Kaptein, A.A., de Borgie, C.A. Middeldorp, S. (2008) The psychological impact of testing for thrombophilia: a systematic review. Journal of Thrombosis and Haemostasis in press).
24. Comp, P.C., Nixon, R.R., Cooper, M.R. Esmon, C.T. (1984) Familial protein S deficiency is associated with recurrent thrombosis. Journal of Clinical Investigation, 74, 2082 2088.
25. Conard, J., Horellou, M.H., van Dreden, P., Lecompte, T. Samama, M. (1990) Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women. Thrombosis & Haemostasis, 63, 319 320.
26. Coppens, M., van Mourik, J.A., Eckmann, C.M., Buller, H.R. Middeldorp, S. (2007) Current practice of testing for hereditary thrombophilia in The Netherlands. Journal of Thrombosis and Haemostasis, 5, 1979 1981.
27. Croft, S.A., Daly, M.E., Steeds, R.P., Channer, K.S., Samani, N.J. Hampton, K.K. (1999) The prothrombin 20210A allele and its association with myocardial infarction. Thrombosis and Haemostasis, 81, 861 864.
28. Crowther, M.A., Ginsberg, J.S., Julian, J., Denburg, J., Hirsh, J., Douketis, J., Laskin, C., Fortin, P., Anderson, D., Kearon, C., Clarke, A., Geerts, W., Forgie, M., Green, D., Costantini, L., Yacura, W., Wilson, S., Gent, M. Kovacs, M.J. (2003) A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. The New England Journal of Medicine, 349, 1133 1138.
29. Cumming, A.M., Tait, R.C., Fildes, S., Yoong, A., Keeney, S. Hay, C.R. (1995) Development of resistance to activated protein C during pregnancy. British Journal of Haematology, 90, 725 727.
30. Curvers, J., Thomassen, M.C., Rimmer, J., Hamulyak, K., van der, M.J., Tans, G., Preston, F.E. Rosing, J. (2002) Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test. Thrombosis and Haemostasis, 88, 5 11.
31. Cushman, M., Rosendaal, F.R., Psaty, B.M., Cook, E.F., Valliere, J., Kuller, L.H. Tracy, R.P. (1998) Factor V Leiden is not a risk factor for arterial vascular disease in the elderly: results from the Cardiovascular Health Study. Thrombosis and Haemostasis, 79, 912 915.
32. Dacosta, A., Tardy-Poncet, B., Isaaz, K., Cerisier, A., Mismetti, P., Simitsidis, S., Reynaud, J., Tardy, B., Piot, M., Decousus, H. Guyotat, D. (1998) Prevalence of factor V Leiden (APCR) and other inherited thrombophilias in young patients with myocardial infarction and normal coronary arteries. Heart, 80, 338 340.
33. Dahlback, B. (1986) Inhibition of protein Ca cofactor function of human and bovine protein S by C4b-binding protein. Journal of Biological Chemistry, 261, 12022 12027.
34. Dahlbäck, B., Carlsson, M. Svensson, P.J. (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proceedings of the National Academy of Sciences of the United States of America, 90, 1004 1008.
35. De Stefano, V., Leone, G., Micalizzi, P., Teofili, L., Falappa, P.G., Pollari, G. Bizzi, B. (1991) Arterial thrombosis as clinical manifestation of congenital protein C deficiency. Annals of Hematology, 62, 180 183.
36. De Stefano, V., Chiusolo, P., Paciaroni, K., Casorelli, I., Rossi, E., Molinari, M., Servidei, S., Tonali, P.A. Leone, G. (1998) Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood, 91, 3562 3565.
37. De Stefano, V., Martinelli, I., Mannucci, P.M., Paciaroni, K., Chiusolo, P., Casorelli, I., Rossi, E. Leone, G. (1999) The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. New England Journal of Medicine, 341, 801 806.
38. De Stefano, V., Simioni, P., Rossi, E., Tormene, D., Za, T., Pagnan, A. Leone, G. (2006) The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S. Haematologica, 91, 695 698.
39. Deruelle, P., Denervaud, M., Hachulla, E., Ducloy-Bouthors, A.S., Valat, A.S., Puech, F., Trillot, N., Hatron, P.Y. Subtil, D. (2006) Use of low-molecular-weight heparin from the first trimester of pregnancy: a retrospective study of 111 consecutive pregnancies. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 127, 73 78.
40. Di Nisio, M., Peters, L.W. Middeldorp, S. (2005) Anticoagulants for the treatment of recurrent pregnancy loss in women without antiphospholipid syndrome. The Cochrane Database of Systematic Reviews, Art. No.: CD004734, DOI:.
41. Doggen, C.J., Cats, V.M., Bertina, R.M. Rosendaal, F.R. (1998) Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. Circulation, 97, 1037 1041.
42. Douay, X., Lucas, C., Caron, C., Goudemand, J. Leys, D. (1998) Antithrombin, protein C and protein S levels in 127 consecutive young adults with ischemic stroke. Acta Neurologica Scandinavica, 98, 124 127.
43. Dykes, A.C., Walker, I.D., McMahon, A.D., Islam, S.I. Tait, R.C. (2001) A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. British Journal of Haematology, 113, 636 641.
44. Egeberg, O. (1965) Inherited antithrombin deficiency causing thrombophilia. Thrombosis et Diathesis Haemorrhagica, 13, 516 530.
45. Eichinger, S., Pabinger, I., Stumpflen, A., Hirschl, M., Bialonczyk, C., Schneider, B., Mannhalter, C., Minar, E., Lechner, K. Kyrle, P.A. (1997) The risk of recurrent venous thromboembolism in patients with and without factor V Leiden. Thrombosis & Haemostasis, 77, 624 628.
46. Eichinger, S., Weltermann, A., Mannhalter, C., Minar, E., Bialonczyk, C., Hirschl, M., Schonauer, V., Lechner, K. Kyrle, P.A. (2002) The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism. Archives of Internal Medicine, 162, 2357 2360.
47. Eichinger, S., Minar, E., Bialonczyk, C., Hirschl, M., Quehenberger, P., Schneider, B., Weltermann, A., Wahl, D.G. Kyrle, P.A. (2003) D-dimer levels and risk of recurrent venous thromboembolism. JAMA, 290, 1071 1074.
48. Empson, M., Lassere, M., Craig, J.C. Scott, J.R. (2005) Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. The Cochrane Database of Systematic Reviews, Art. No.: CD002859, DOI:.
49. Esmon, C.T. (2000) Regulation of blood coagulation. Biochimica et Biophysica Acta, 1477, 349 360.
50. Finazzi, G., Marchioli, R., Brancaccio, V., Schinco, P., Wisloff, F., Musial, J., Baudo, F., Berrettini, M., Testa, S., D'Angelo, A., Tognoni, G. Barbui, T. (2005) A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). Journal of Thrombosis and Haemostasis, 3, 848 853.
51. Galli, M. Barbui, T. (2005) Antiphospholipid syndrome: clinical and diagnostic utility of laboratory tests. Seminars in Thrombosis and Hemostasis, 31, 17 24.
52. Galli, M., Luciani, D., Bertolini, G. Barbui, T. (2003) Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood, 101, 1827 1832.
53. Gandrille, S., Borgel, D., Ireland, H., Lane, D.A., Simmonds, R., Reitsma, P.H., Mannhalter, C., Pabinger, I., Saito, H., Suzuki, K., Formstone, C., Cooper, D.N., Espinosa, Y., Sala, N., Bernardi, F. Aiach, M. (1997) Protein S deficiency: a database of mutations. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thrombosis & Haemostasis, 77, 1201 1214.
54. Gandrille, S., Borgel, D., Sala, N., Espinosa-Parrilla, Y., Simmonds, R., Rezende, S., Lind, B., Mannhalter, C., Pabinger, I., Reitsma, P.H., Formstone, C., Cooper, D.N., Saito, H., Suzuki, K., Bernardi, F. Aiach, M. (2000) Protein S deficiency: a database of mutations-summary of the first update. Thrombosis & Haemostasis, 84, 918.
55. Ganesan, V., McShane, M.A., Liesner, R., Cookson, J., Hann, I. Kirkham, F.J. (1998) Inherited prothrombotic states and ischaemic stroke in childhood. Journal of Neurology, Neurosurgery, and Psychiatry, 65, 508 511.
56. Ginsburg, K.S., Liang, M.H., Newcomer, L., Goldhaber, S.Z., Schur, P.H., Hennekens, C.H. Stampfer, M.J. (1992) Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Annals of Internal Medicine, 117, 997 1002.
57. Girolami, A., Simioni, P., Lazzaro, A.R. Cordiano, I. (1989) Severe arterial cerebral thrombosis in a patient with protein S deficiency (moderately reduced total and markedly reduced free protein S): a family study. Thrombosis and Haemostasis, 61, 144 147.
58. Green, D., Otoya, J., Oriba, H. Rovner, R. (1992) Protein S deficiency in middle-aged women with stroke. Neurology, 42, 1029 1033.
59. Grewal, R.P. Goldberg, M.A. (1990) Stroke in protein C deficiency. American Journal of Medicine, 89, 538 539.
60. Griffin, J.H., Evatt, B., Zimmerman, T.S., Kleiss, A.J. Wideman, C. (1981) Deficiency of protein C in congenital thrombotic disease. Journal of Clinical Investigation, 68, 1370 1373.
61. Gris, J.C., Mercier, E., Quere, I., Lavigne-Lissalde, G., Cochery-Nouvellon, E., Hoffet, M., Ripart-Neveu, S., Tailland, M.L., Dauzat, M. Mares, P. (2004) Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood, 103, 3695 3699.
62. de Groot, P.G., Lutters, B., Derksen, R.H., Lisman, T., Meijers, J.C. Rosendaal, F.R. (2005) Lupus anticoagulants and the risk of a first episode of deep venous thrombosis. Journal of Thrombosis and Haemostasis, 3, 1993 1997.
63. Gunther, G., Junker, R., Strater, R., Schobess, R., Kurnik, K., Heller, C., Kosch, A. Nowak-Gottl, U. (2000) Symptomatic ischemic stroke in full-term neonates: role of acquired and genetic prothrombotic risk factors. Stroke, 31, 2437 2441.
64. Hackeng, T.M., van 't Veer, C., Meijers, J.C. Bouma, B.N. (1994) Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa. Journal of Biological Chemistry, 269, 21051 21058.
65. Hankey, G.J., Eikelboom, J.W., van Bockxmeer, F.M., Lofthouse, E., Staples, N. Baker, R.I. (2001) Inherited thrombophilia in ischemic stroke and its pathogenic subtypes. Stroke, 32, 1793 1799.
66. Hayashi, K., Sone, T., Kondoh, J., Tsuboi, H., Sassa, H., Numaguchi, Y., Toki, Y., Okumura, K., Ito, T. Hayakawa, T. (1997) Prevalence of activated protein C resistance in acute myocardial infarction in Japan. Japanese Heart Journal, 38, 769 778.
67. Heeb, M.J., Kojima, Y., Greengard, J.S. Griffin, J.H. (1995) Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V. Blood, 85, 3405 3411.
68. Heijboer, H., Brandjes, D.P., Buller, H.R., Sturk, A. ten Cate, J.W. (1990) Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. New England Journal of Medicine, 323, 1512 1516.
69. Henkens, C.M., Bom, V.J., Seinen, A.J. van der Meer, J. (1995) Sensitivity to activated protein C; influence of oral contraceptives and sex. Thrombosis & Haemostasis, 73, 402 404.
70. Hirsh, J., Piovella, F. Pini, M. (1989) Congenital antithrombin III deficiency. Incidence and clinical features. American Journal of Medicine, 87, 34S 38S.
71. van Hylckama Vlieg, A., van der Linden, I.K., Bertina, R.M. Rosendaal, F.R. (2000) High levels of factor IX increase the risk of venous thrombosis. Blood, 95, 3678 3682.
72. van Hylckama Vlieg, A., Baglin, C.A., Bare, L.A., Rosendaal, F.R. Baglin, T.P. (2008) Proof of principle of potential clinical utility of multiple SNP analysis for prediction of recurrent venous thrombosis. Journal of Thrombosis and Haemostasis, 6, 751 754.
73. Jauniaux, E., Farquharson, R.G., Christiansen, O.B. Exalto, N. (2006) Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Human Reproduction, 21, 2116 2222.
74. Juul, K., Tybjaerg-Hansen, A., Steffensen, R., Kofoed, S., Jensen, G. Nordestgaard, B.G. (2002) Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses. Blood, 100, 3 10.
75. Kalafatis, M., Bertina, R.M., Rand, M.D. Mann, K.G. (1995) Characterization of the molecular defect in factor VR506Q. Journal of Biological Chemistry, 270, 4053 4057.
76. Kamphuisen, P.W., Lensen, R., Houwing-Duistermaat, J.J., Eikenboom, J.C., Harvey, M., Bertina, R.M. Rosendaal, F.R. (2000) Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia. British Journal Haematology, 109, 519 522.
77. Kamphuisen, P.W., Eikenboom, J.C., Rosendaal, F.R., Koster, T., Blann, A.D., Vos, H.L. Bertina, R.M. (2001) High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene. British Journal of Haematology, 115, 156 158.
78. Kearon, C., Gent, M., Hirsh, J., Weitz, J., Kovacs, M.J., Anderson, D.R., Turpie, A.G., Green, D., Ginsberg, J.S., Wells, P., MacKinnon, B. Julian, J.A. (1999) A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine, 340, 901 907.
79. Kearon, C., Ginsberg, J.S., Kovacs, M.J., Anderson, D.R., Wells, P., Julian, J.A., MacKinnon, B., Weitz, J.I., Crowther, M.A., Dolan, S., Turpie, A.G., Geerts, W., Solymoss, S., van Nguyen, P., Demers, C., Kahn, S.R., Kassis, J., Rodger, M., Hambleton, J. Gent, M. (2003) Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. The New England Journal of Medicine, 349, 631 639.
80. Kenet, G., Sadetzki, S., Murad, H., Martinowitz, U., Rosenberg, N., Gitel, S., Rechavi, G. Inbal, A. (2000) Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke, 31, 1283 1288.
81. Khamashta, M.A., Cuadrado, M.J., Mujic, F., Taub, N.A., Hunt, B.J. Hughes, G.R. (1995) The management of thrombosis in the antiphospholipid- antibody syndrome. New England Journal of Medicine, 332, 993 997.
82. Koeleman, B.P., Reitsma, P.H. Bertina, R.M. (1997) Familial thrombophilia: a complex genetic disorder. Seminars in Hematology, 34, 256 264.
83. Kohler, J., Kasper, J., Witt, I. von Reutern, G.M. (1990) Ischemic stroke due to protein C deficiency. Stroke, 21, 1077 1080.
84. van Korlaar, I., Vossen, C.Y., Rosendaal, F.R., Bovill, E.G., Naud, S., Cameron, L.D. Kaptein, A.A. (2005) Attitudes toward genetic testing for thrombophilia in asymptomatic members of a large family with heritable protein C deficiency. Journal of Thrombosis and Haemostasis, 3, 2437 2444.
85. Koster, T., Rosendaal, F.R., de Ronde, H., Briët, E., Vandenbroucke, J.P. Bertina, R.M. (1993) Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet, 342, 1503 1506.
86. Koster, T., Rosendaal, F.R., Reitsma, P.H., van der Velden, P.A., Briët, E. Vandenbroucke, J.P. (1994) Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms-the Leiden Thrombophilia Study (LETS). Thrombosis and Haemostasis, 71, 719 722.
87. Koster, T., Briët, E., van der Meer, F.J., Colly, L.P., Trienekens, P.H., Poort, S.R., Reitsma, P.H. Vandenbroucke, J.P. (1995a) Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study). Blood, 85, 2756 2761.
88. Koster, T., Blann, A.D., Briët, E., Vandenbroucke, J.P. Rosendaal, F.R. (1995b) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet, 345, 152 155.
89. Kraaijenhagen, R.A., in't Anker, P.S., Koopman, M.M., Reitsma, P.H., Prins, M.H., van den, E.A. Buller, H.R. (2000) High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thrombosis & Haemostasis, 83, 5 9.
90. Kyrle, P.A., Minar, E., Hirschl, M., Bialonczyk, C., Stain, M., Schneider, B., Weltermann, A., Speiser, W., Lechner, K. Eichinger, S. (2000) High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. New England Journal of Medicine, 343, 457 462.
91. Lalouschek, W., Schillinger, M., Hsieh, K., Endler, G., Tentschert, S., Lang, W., Cheng, S. Mannhalter, C. (2005) Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years. Stroke, 36, 1405 1409.
92. Lane, D.A., Olds, R.J., Boisclair, M., Chowdhury, V., Thein, S.L., Cooper, D.N., Blajchman, M., Perry, D., Emmerich, J. Aiach, M. (1993) Antithrombin III mutation database: first update. For the Thrombin and its Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thrombosis & Haemostasis, 70, 361 369.
93. Lane, D.A., Bayston, T., Olds, R.J., Fitches, A.C., Cooper, D.N., Millar, D.S., Jochmans, K., Perry, D.J., Okajima, K., Thein, S.L. Emmerich, J. (1997) Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thrombosis & Haemostasis, 77, 197 211.
94. Legnani, C., Razzaboni, E., Gremigni, P., Ricci Bitti, P.E., Favaretto, E. Palareti, G. (2006) Psychological impact of testing for thrombophilic alterations. Thrombosis & Haemostasis, 96, 348 355.
95. Lim, W., Crowther, M.A. Eikelboom, J.W. (2006) Management of antiphospholipid antibody syndrome: a systematic review. JAMA, 295, 1050 1057.
96. Lindmarker, P., Schulman, S., Sten-Linder, M., Wiman, B., Egberg, N. Johnsson, H. (1999) The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation. Thrombosis and Haemostasis JID - 7608063, 81, 684 689.
97. Longstreth, Jr., W.T., Rosendaal, F.R., Siscovick, D.S., Vos, H.L., Schwartz, S.M., Psaty, B.M., Raghunathan, T.E., Koepsell, T.D. Reitsma, P.H. (1998) Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A). Stroke, 29, 577 580.
98. Machin, S.J. (2003) Pros and cons of thrombophilia testing: cons. Journal of Thrombosis and Haemostasis, 1, 412 413.
99. Mahasandana, C., Suvatte, V., Marlar, R.A., Manco-Johnson, M.J., Jacobson, L.J. Hathaway, W.E. (1990) Neonatal purpura fulminans associated with homozygous protein S deficiency [letter]. Lancet, 335, 61 62.
100. Makris, M., Preston, F.E., Beauchamp, N.J., Cooper, P.C., Daly, M.E., Hampton, K.K., Bayliss, P., Peake, I.R. Miller, G.J. (1997) Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thrombosis & Haemostasis, 78, 1426 1429.
101. Mansourati, J., Da Costa, A., Munier, S., Mercier, B., Tardy, B., Ferec, C., Isaaz, K. Blanc, J.J. (2000) Prevalence of factor V Leiden in patients with myocardial infarction and normal coronary angiography. Thrombosis and Haemostasis, 83, 822 825.
102. Manzar, K.J., Padder, F.A., Conrad, A.R., Freeman, I. Jonas, E.A. (1997) Acute myocardial infarction with normal coronary artery: a case report and review of literature. American Journal of the Medical Sciences, 314, 342 345.
103. Marchetti, M., Pistorio, A. Barosi, G. (2000) Extended anticoagulation for prevention of recurrent venous thromboembolism in carriers of factor V Leiden: cost-effectiveness analysis. Thrombosis & Haemostasis, 84, 752 757.
104. Marlar, R.A., Montgomery, R.R. Broekmans, A.W. (1989) Report on the diagnosis and treatment of homozygous protein C deficiency. Report of the Working Party on Homozygous Protein C Deficiency of the ICTH-Subcommittee on Protein C and Protein S. Thrombosis & Haemostasis, 61, 529 531.
105. Martinez, H.R., Rangel-Guerra, R.A. Marfil, L.J. (1993) Ischemic stroke due to deficiency of coagulation inhibitors. Report of 10 young adults. Stroke, 24, 19 25.
106. van der Meer, F.J., Rosendaal, F.R., Vandenbroucke, J.P. Briet, E. (1996) Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants. Thrombosis & Haemostasis, 76, 12 16.
107. Meijers, J.C.M., Tekelenburg, W.L.H., Bouma, B.N., Bertina, R.M. Rosendaal, F.R. (2000) High levels of factor XI as a risk factor for venous thrombosis. New England Journal of Medicine, 342, 696 701.
108. Meinardi, J.R., Henkens, C.M., Heringa, M.P. van der Meer, J. (1997) Acquired APC resistance related to oral contraceptives and pregnancy and its possible implications for clinical practice. Blood Coagulation & Fibrinolysis, 8, 152 154.
109. Meinardi, J.R., Middeldorp, S., de Kam, P.J., Koopman, M.M.W., van Pampus, E.C.M., Hamulyak, K., Prins, M.H., Buller, H.R. van der Meer, J. (1999) Increased risk for fetal loss in carriers of the factor V Leiden mutation. Annals of Internal Medicine, 130, 736 739.
110. Meinardi, J.R., Middeldorp, S., de Kam, P.J., Koopman, M.M.W., van Pampus, E.C.M., Hamulyak, K., Prins, M.H., Buller, H.R. van der Meer, J. (2001) Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect. Blood Coagulation & Fibrinolysis, 12, 713 720.
111. Meinardi, J.R., Middeldorp, S., de Kam, P.J., Koopman, M.M.W., van Pampus, E.C.M., Hamulyak, K., Prins, M.H., Buller, H.R. van der Meer, J. (2002) The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders. British Journal of Haematology, 116, 625 631.
112. Middeldorp, S. (2007a) Thrombophilia and pregnancy complications: cause or association? Journal of Thrombosis and Haemostasis, 5, 276 282.
113. Middeldorp, S. (2007b) Pregnancy failure and heritable thrombophilia. Seminars in Hematology, 44, 93 97.
114. Miles, J.S., Miletich, J.P., Goldhaber, S.Z., Hennekens, C.H. Ridker, P.M. (2001) G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism. Journal of the American College of Cardiology, 37, 215 218.
115. Miletich, J., Sherman, L. Broze, Jr., G. (1987) Absence of thrombosis in subjects with heterozygous protein C deficiency. New England Journal of Medicine, 317, 991 996.
116. Miyakis, S., Lockshin, M.D., Atsumi, T., Branch, D.W., Brey, R.L., Cervera, R., Derksen, R.H., de Groot, P.G., Koike, T., Meroni, P.L., Reber, G., Shoenfeld, Y., Tincani, A., Vlachoyiannopoulos, P.G. Krilis, S.A. (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). Journal of Thrombosis and Haemostasis, 4, 295 306.
117. Munts, A.G., van Genderen, P.J., Dippel, D.W., van Kooten, F. Koudstaal, P.J. (1998) Coagulation disorders in young adults with acute cerebral ischaemia. Journal of Neurology, 245, 21 25.
118. Naess, I.A., Christiansen, S.C., Cannegieter, S.C., Rosendaal, F.R. Hammerstroem, J. (2006) A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study). Journal of Thrombosis and Haemostasis, 4, 44 49.
119. Nicolaes, G.A., Tans, G., Thomassen, M.C.L.G.D., Hemker, H.C., Pabinger, I., Varadi, K., Schwarz, H.P. Rosing, J. (1995) Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C. Journal of Biological Chemistry, 270, 21158 21166.
120. O'Donnell, J. Laffan, M. (2001) Elevated plasma factor VIII levels-a novel risk factor for venous thromboembolism. Clinical Laboratory, 47, 1 6.
121. Olivieri, O., Friso, S., Manzato, F., Guella, A., Bernardi, F., Lunghi, B., Girelli, D., Azzini, M., Brocco, G., Russo, C. Corrocher, R. (1995) Resistance to activated protein C in healthy women taking oral contraceptives. British Journal Haematology, 91, 465 470.
122. Opatrny, L., David, M., Kahn, S.R., Shrier, I. Rey, E. (2006) Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmunie disease: a metaanalysis. Journal of Rheumatology, 33, 2214 2221.
123. Pabinger, I., Brucker, S., Kyrle, P.A., Schneider, B., Korninger, H.C., Niessner, H. Lechner, K. (1992) Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening. Blood Coagulation & Fibrinolysis, 3, 547 553.
124. Palareti, G., Leali, N., Coccheri, S., Poggi, M., Manotti, C., D'Angelo, A., Pengo, V., Erba, N., Moia, M., Ciaverella, N., Devoto, G., Berrettini, M. Musolesi, S. (1996) Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet, 348, 423 428.
125. Palareti, G., Legnani, C., Cosmi, B., Guazzaloca, G., Pancani, C. Coccheri, S. (2002) Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped. Thrombosis and Haemostasis, 87, 7 12.
126. Peterman, M.A. Roberts, W.C. (2003) Syndrome of protein C deficiency and anterior wall acute myocardial infarction at a young age from a single coronary occlusion with otherwise normal coronary arteries. American Journal of Cardiology, 92, 768 770.
127. Pezzini, A., Grassi, M., Del, Z.E., Archetti, S., Spezi, R., Vergani, V., Assanelli, D., Caimi, L. Padovani, A. (2005) Cumulative effect of predisposing genotypes and their interaction with modifiable factors on the risk of ischemic stroke in young adults. Stroke, 36, 533 539.
128. Pomp, E.R., Le Cessie, S., Rosendaal, F.R. Doggen, C.J. (2007) Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. British Journal of Haematology, 132, 289 296.
129. Poort, S.R., Rosendaal, F.R., Reitsma, P.H. Bertina, R.M. (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood, 88, 3698 3703.
130. Prandoni, P., Lensing, A.W., Cogo, A., Cuppini, S., Villalta, S., Carta, M., Cattelan, A.M., Polistena, P., Bernardi, E. Prins, M.H. (1996a) The long-term clinical course of acute deep venous thrombosis. Annals of Internal Medicine, 125, 1 7.
131. Prandoni, P., Simioni, P. Girolami, A. (1996b) Antiphospholipid antibodies, recurrent thromboembolism, and intensity of warfarin anticoagulation. Thrombosis and Haemostasis, 75, 859.
132. Preston, F.E., Rosendaal, F.R., Walker, I.D., Briet, E., Berntorp, E., Conard, J., Fontcuberta, J., Makris, M., Mariani, G., Noteboom, W., Pabinger, I., Legnani, C., Scharrer, I., Schulman, S. van der Meer, F.J.M. (1996) Increased fetal loss in women with heritable thrombophilia. Lancet, 348, 913 916.
133. Rai, R. Regan, L. (2006) Recurrent miscarriage. The Lancet, 368, 601 611.
134. Rallidis, L.S., Belesi, C.I., Manioudaki, H.S., Chatziioakimidis, V.K., Fakitsa, V.C., Sinos, L.E., Laoutaris, N.P. Apostolou, T.S. (2003) Myocardial infarction under the age of 36: prevalence of thrombophilic disorders. Thrombosis and Haemostasis, 90, 272 278.
135. Rance, A., Emmerich, J. Fiessinger, J.N. (1997) Anticardiolipin antibodies and recurrent thromboembolism. Thrombosis and Haemostasis, 77, 221 222.
136. Rees, D.C. (1996) The population genetics of factor V Leiden (Arg506Gln). British Journal of Haematology, 95, 579 586.
137. Reitsma, P.H., Bernardi, F., Doig, R.G., Gandrille, S., Greengard, J.S., Ireland, H., Krawczak, M., Lind, B., Long, G.L., Poort, S.R., Saito, H., Sala, N., Witt, I. Cooper, D.N. (1995) Protein C deficiency: a database of mutations, 1995 update. On behalf of the Subcommittee on Plasma Coagulation Inhibitors of the Scientific and Standardization Committee of the ISTH. Thrombosis & Haemostasis, 73, 876 889.
138. Rey, E., Kahn, S.R., David, M. Shrier, I. (2003) Thrombophilic disorders and fetal loss: a meta-analysis. Lancet, 361, 901 908.
139. Ridker, P.M., Hennekens, C.H., Lindpaintner, K., Stampfer, M.J., Eisenberg, P.R. Miletich, J.P. (1995a) Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. New England Journal of Medicine, 332, 912 917.
140. Ridker, P.M., Hennekens, C.H., Lindpaintner, K., Stampfer, M.J., Eisenberg, P.R. Miletich, J.P. (1995b) Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. The New England Journal of Medicine, 332, 912 917.
141. Ridker, P.M., Hennekens, C.H. Miletich, J.P. (1999) G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men. Circulation, 99, 999 1004.
142. Rintelen, C., Pabinger, I., Knobl, P., Lechner, K. Mannhalter, C. (1996) Probability of recurrence of thrombosis in patients with and without factor V Leiden. Thrombosis & Haemostasis, 75, 229 232.
143. Robertson, L., Wu, O., Langhorne, P., Twaddle, S., Clark, P., Lowe, G.D.O., Walker, I.D., Greaves, M., Brenkel, I., Regan, L. Greer, I.A. (2006) Thrombophilia in pregnancy: a systematic review. British Journal of Haematology, 132, 171 196.
144. Rodeghiero, F. Tosetto, A. (1999) Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism. Annals of Internal Medicine, 130, 643 650.
145. Rodger, M.A., Paidas, M.J., Mclintock, C., Middeldorp, S., Kahn, S.R., Martinelli, I., Hague, W., Rosene-Montella, S. Greer, I.A. (2008) Inherited thrombophilia and pregnancy complications revisited: association not proven causal and antithrombotic prophylaxis is experimental. Obstetrics and Gynecology in press).
146. Rosendaal, F.R., Koster, T., Vandenbroucke, J.P. Reitsma, P.H. (1995) High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood, 85, 1504 1508.
147. Rosendaal, F.R., Siscovick, D.S., Schwartz, S.M., Beverly, R.K., Psaty, B.M., Longstreth, Jr., W.T., Raghunathan, T.E., Koepsell, T.D. Reitsma, P.H. (1997) Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood, 89, 2817 2821.
148. Rosendaal, F.R., Doggen, C.J., Zivelin, A., Arruda, V.R., Aiach, M., Siscovick, D.S., Hillarp, A., Watzke, H.H., Bernardi, F., Cumming, A.M., Preston, F.E. Reitsma, P.H. (1998) Geographic distribution of the 20210 G to A prothrombin variant. Thrombosis and Haemostasis, 79, 706 708.
149. Rosing, J., Tans, G., Nicolaes, G.A., Thomassen, M.C.L.G.D., van Oerle, R., van der Ploeg, P.M., Heijnen, P., Hamulyak, K. Hemker, H.C. (1997) Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives. British Journal of Haematology, 97, 233 238.
150. Ruiz-Irastorza, G., Hunt, B.J. Khamashta, M.A. (2007) A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies. Arthritis and Rheumatism, 57, 1487 1495.
151. Runchey, S.S., Folsom, A.R., Tsai, M.Y., Cushman, M. McGovern, P.D. (2002) Anticardiolipin antibodies as a risk factor for venous thromboembolism in a population-based prospective study. British Journal of Haematology, 119, 1005 1010.
152. Sanson, B.J., Friederich, P.W., Simioni, P., Zanardi, S., Huisman, M.V., Girolami, A., Cate, J.W.P. Prins, M.H. (1996) The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women. Thrombosis & Haemostasis, 75, 387 388.
153. Sanson, B.J., Simioni, P., Tormene, D., Moia, M., Friederich, P.W., Huisman, M.V., Prandoni, P., Bura, A., Rejto, L., Wells, P., Mannucci, P.M., Girolami, A., Buller, H.R. Prins, M.H. (1999) The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study. Blood, 94, 3702 3706.
154. Schulman, S., Svenungsson, E. Granqvist, S. (1998) Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. American Journal of Medicine, 104, 332 338.
155. Segev, A., Ellis, M.H., Segev, F., Friedman, Z., Reshef, T., Sparkes, J.D., Tetro, J., Pauzner, H. David, D. (2005) High prevalence of thrombophilia among young patients with myocardial infarction and few conventional risk factors. International Journal of Cardiology, 98, 421 424.
156. Simioni, P., Sanson, B.J., Prandoni, P., Tormene, D., Friederich, P.W., Girolami, B., Gavasso, S., Huisman, M.V., Buller, H.R., ten Cate, J.W., Girolami, A. Prins, M.H. (1999) The incidence of venous thromboembolism in families with inherited thrombophilia. Thrombosis & Haemostasis, 81, 198 202.
157. Simioni, P., Prandoni, P., Lensing, A.W., Manfrin, D., Tormene, D., Gavasso, S., Girolami, B., Sardella, C., Prins, M. Girolami, A. (2000) Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis. Blood JID - 7603509, 96, 3329 3333.
158. Smiles, A.M., Jenny, N.S., Tang, Z., Arnold, A., Cushman, M. Tracy, R.P. (2002) No association of plasma prothrombin concentration or the G20210A mutation with incident cardiovascular disease: results from the Cardiovascular Health Study. Thrombosis and Haemostasis, 87, 614 621.
159. Stearns-Kurosawa, D.J., Kurosawa, S., Mollica, J.S., Ferrell, G.L. Esmon, C.T. (1996) The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proceedings of the National Academy of Sciences of the United States of America, 93, 10212 10216.
160. Tait, R.C., Walker, I.D., Perry, D.J., Islam, S.I., Daly, M.E., McCall, F., Conkie, J.A. Carrell, R.W. (1994) Prevalence of antithrombin deficiency in the healthy population. British Journal of Haematology, 87, 106 112.
161. Tans, G., Curvers, J., Middeldorp, S., Thomassen, M.C.L.G.D., Meijers, J.C.M., Prins, M.H., Bouma, B.N., Buller, H.R. Rosing, J. (2000) A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways. Thrombosis & Haemostasis, 84, 15 21.
162. Tans, G., van Hylckama Vlieg, A., Thomassen, M.C., Curvers, J., Bertina, R.M., Rosing, J. Rosendaal, F.R. (2003) Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women. British Journal of Haematology, 122, 465 470.
163. Taylor, Jr., F.B., Peer, G.T., Lockhart, M.S., Ferrell, G. Esmon, C.T. (2001) Endothelial cell protein C receptor plays an important role in protein C activation in vivo. Blood, 97, 1685 1688.
164. Tiong, I.Y., Alkotob, M.L. Ghaffari, S. (2003) Protein C deficiency manifesting as an acute myocardial infarction and ischaemic stroke. Heart, 89, E7.
165. Urbanus, R.T., Derksen, R.H. de Groot, P.G. (2008) Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome. Blood Reviews, 22, 93 105.
166. Vandenbroucke, J.P., Koster, T., Briët, E., Reitsma, P.H., Bertina, R.M. Rosendaal, F.R. (1994) Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet, 344, 1453 1457.
167. deVeber, G., Monagle, P., Chan, A., MacGregor, D., Curtis, R., Lee, S., Vegh, P., Adams, M., Marzinotto, V., Leaker, M., Massicotte, M.P., Lillicrap, D. Andrew, M. (1998) Prothrombotic disorders in infants and children with cerebral thromboembolism. Archives of Neurology, 55, 1539 1543.
168. Vink, R., Kraaijenhagen, R.A., Levi, M. Buller, H.R. (2003) Individualised duration of oral anticoagulant therapy for deep vein thrombosis based on a decision model. Journal of Thrombosis and Haemostasis, 1, 2523 2530.
169. Virchow, R. (1856) Thrombose und Embolie. Gefässentzündung und septische Infektion. Gesammelte Abhandlungen zur wissenschaftlichen Medicin. Von Meidinger & Sohn, Frankfurt am Main.
170. de Visser, M.C.H., Rosendaal, F.R. Bertina, R.M. (1999) A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis. Blood, 93, 1271 1276.
171. Voorberg, J., Roelse, J., Koopman, R., Büller, H.R., Berends, F., ten Cate, J.W., Mertens, K. van Mourik, J.A. (1994) Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V. Lancet, 343, 1535 1536.
172. Vossen, C.Y., Hasstedt, S.J., Rosendaal, F.R., Callas, P.W., Bauer, K.A., Broze, G.J., Hoogendoorn, H., Long, G.L., Scott, B.T. Bovill, E.G. (2004) Heritability of plasma concentrations of clotting factors and measures of a prethrombotic state in a protein C-deficient family. Journal of Thrombosis and Haemostasis, 2, 242 247.
173. Vossen, C.Y., Conard, J., Fontcuberta, J., Makris, M., van der Meer, F.J., Pabinger, I., Palareti, G., Preston, F.E., Scharrer, I., Souto, J.C., Svensson, P., Walker, I.D. Rosendaal, F.R. (2005) Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). Journal of Thrombosis and Haemostasis, 3, 459 464.
174. Walker, M.C., Ferguson, S.E. Allen, V.M. (2003) Heparin for pregnant women with acquired or inherited thrombophilias. The Cochrane Database of Systematic Reviews, Art. No.: CD003580, DOI:.
175. Weitz, J.I., Middeldorp, S., Geerts, W. Heit, J.A. (2004) Thrombophilia and new anticoagulant drugs. Hematology (Am Soc Hematol Educ Program), 2004, 424 438.
176. Weltermann, A., Eichinger, S., Bialonczyk, C., Minar, E., Hirschl, M., Quehenberger, P., Schonauer, V. Kyrle, P.A. (2003) The risk of recurrent venous thromboembolism among patients with high factor IX levels. Journal of Thrombosis and Haemostasis, 1, 28 32.
177. Wilson, W.A., Gharavi, A.E., Koike, T., Lockshin, M.D., Branch, D.W., Piette, J.C., Brey, R., Derksen, R., Harris, E.N., Hughes, G.R., Triplett, D.A. Khamashta, M.A. (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis and Rheumatism, 42, 1309 1311.
178. Wu, O., Robertson, L., Twaddle, S., Lowe, G.D., Clark, P., Greaves, M., Walker, I.D., Langhorne, P., Brenkel, I., Regan, L. Greer, I. (2006) Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technology Assessment, 10, 1 110.
179. Zanon, E., Prandoni, P., Vianello, F., Saggiorato, G., Carraro, G., Bagatella, P. Girolami, A. (1999) Anti-beta2-glycoprotein I antibodies in patients with acute venous thromboembolism: prevalence and association with recurrent thromboembolism. Thrombosis Research, 96, 269 274.
180. Zenz, W., Bodo, Z., Plotho, J., Streif, W., Male, C., Bernert, G., Rauter, L., Ebetsberger, G., Kaltenbrunner, K., Kurnik, P., Lischka, A., Paky, F., Ploier, R., Hofler, G., Mannhalter, C. Muntean, W. (1998) Factor V Leiden and prothrombin gene G 20210 A variant in children with ischemic stroke. Thrombosis and Haemostasis, 80, 763 766.
181. Zoller, B., Berntsdotter, A., Garcia de Frutos, P. Dahlback, B. (1995) Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood, 85, 3518 3523.